April 03, 2021
Article
Nearly 20% of the world’s cancer cases are caused by viruses, and 7 viruses have been documented to cause this aggregate number of cancer cases, with HPV being the most well recognized.
January 27, 2021
Article
In this trial, the previous observation of liver toxicity using CD137 agonism was not observed, suggesting a safe neoadjuvant dosing. Indeed, 30% of patients demonstrated pathologic responses. Further research may combine a way of overcoming immune checkpoint pathways with stimulatory agonists.
April 09, 2016
Video
Robert Ferris, MD, PhD, discusses the potential impact the CheckMate-141 study could have regarding nivolumab as potential treatment for patients with head and neck cancer.